These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8142022)

  • 1. Long-term expression of human factor IX cDNA in rabbits.
    Zhou JM; Qiu XF; Lu DR; Lu JY; Xue JL
    Sci China B; 1993 Nov; 36(11):1333-41. PubMed ID: 8142022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
    Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
    Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I clinical trial of gene therapy for hemophilia B.
    Lu DR; Zhou JM; Zheng B; Qiu XF; Xue JL; Wang JM; Meng PL; Han FL; Ming BH; Wang XP
    Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
    Dai YF; Qiu XF; Xue JL; Liu ZD
    Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
    Yao SN; Smith KJ; Kurachi K
    Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards gene therapy for hemophilia B.
    Anson DS; Hock RA; Austen D; Smith KJ; Brownlee GG; Verma IM; Miller AD
    Mol Biol Med; 1987 Feb; 4(1):11-20. PubMed ID: 3475525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
    Lu D; Qiu X; Zheng B; Qiu X; Xue J
    Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards gene therapy for haemophilia B using primary human keratinocytes.
    Gerrard AJ; Hudson DL; Brownlee GG; Watt FM
    Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The three in-frame ATG, clustered in the translation initiation sequence of human factor IX gene, are required for an optimal protein production.
    Enjolras N; Rodriguez MH; Plantier JL; Maurice M; Attali O; Négrier C
    Thromb Haemost; 1999 Oct; 82(4):1264-9. PubMed ID: 10544911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo fibroblast transduction in rabbits results in long-term (>600 days) factor IX expression in a small percentage of animals.
    Chen L; Nelson DM; Zheng Z; Morgan RA
    Hum Gene Ther; 1998 Nov; 9(16):2341-51. PubMed ID: 9829533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast transplantation in rats: transduction and function of foreign genes.
    Neuzil D; Holzman M; Rozga J; Levine J; Moscioni AD; Demetriou AA
    J Surg Res; 1993 Jun; 54(6):631-7. PubMed ID: 8412074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX.
    Bigger BW; Siapati EK; Mistry A; Waddington SN; Nivsarkar MS; Jacobs L; Perrett R; Holder MV; Ridler C; Kemball-Cook G; Ali RR; Forbes SJ; Coutelle C; Wright N; Alison M; Thrasher AJ; Bonnet D; Themis M
    Gene Ther; 2006 Jan; 13(2):117-26. PubMed ID: 16163377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
    Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
    J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor IX gene therapy for hemophilia.
    Fewell JG
    Methods Mol Biol; 2008; 423():375-82. PubMed ID: 18370215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
    Wen J; Vargas AG; Ofosu FA; Hortelano G
    J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent expression of canine factor IX in hemophilia B canines.
    Chao H; Samulski R; Bellinger D; Monahan P; Nichols T; Walsh C
    Gene Ther; 1999 Oct; 6(10):1695-704. PubMed ID: 10516718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.